Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.
684% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $167K
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
0% more funds holding
Funds holding: 177 → 177 (0)
3% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 62
4% less capital invested
Capital invested by funds: $615M → $592M (-$22.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.08M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.48M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$4.24M |
| 4 |
Morgan Stanley
New York
|
+$2.97M |
| 5 |
Renaissance Technologies
New York
|
+$2.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.2M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$2.05M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.93M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.58M |
VIVO Hedge Fund Activity: Q3 2018 in Review
177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.
The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.
- 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
- 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
- The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.
Based on aggregated 13F filings for Q3 2018.